UNSPSC 51323003: Carnitine chloride

This classification denotes a nutritional supplement with the molecular formula C7H16NO3.Cl, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F64264D63N, chemically known as dl-(3-carboxy-2-hydroxypropyl)trimethylammonium hydroxide inner salt hydrochloride, but more generally known as carnitine chloride, which bears US NIH Compound Identifier 5970. European Medicines Agency schedules carnitine chloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06134MIG.

Most nations, for tariff purposes, schedule carnitine chloride under HS 29239000. SMILES: C[N+](C)(C)CC(CC(=O)O)O.[CL-].

UNSPSC 51323003 Carnitine chloride (Commodity) represents a narrow pharmaceutical ingredient category that state and local governments procure primarily as part of broader advanced life support and emergency medical service medication programs. While the code nominally identifies a single chemical compound, recent state and local solicitations show that carnitine chloride and related pharmaceuticals are typically acquired through bundled medication procurement vehicles rather than as standalone line items. The Tampa Fire Rescue solicitation (26P00188) illustrates the actual procurement pattern: the City of Tampa's Purchasing Department issued an IFB for Advanced Life Support Medications bundling multiple drug compounds for emergency response, with delivery requirements, expiration-date warranties, and firm pricing inclusive of freight to the point of use. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products similarly shows that manufacturers and distributors supply carnitine chloride and comparable agents as part of state and local health system formularies serving multiple jurisdictions and authorized wholesalers including AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., LLC.

The code shows recent activity concentrated in Texas, Florida, and Minnesota. The Tampa Fire Rescue solicitation (posted April 24, 2026, closed April 8, 2026) carried an estimated contract value of $40,000.00 with a one-year initial term and two optional one-year renewals, while the MMCAP RFP (posted January 20, 2026, due March 26, 2026) serves a multistate cooperative purchasing vehicle spanning Minnesota and Oregon with a two-year contract term and sole-discretion extension options. The Texas Health and Human Services Commission's RFI (posted April 3, 2026) on direct-to-manufacturer prescriptions signals emerging state interest in alternative pharmacy benefit models that may expand carnitine chloride procurement pathways beyond traditional GPO and wholesaler channels. Issuing bodies include city fire and rescue departments, state health agencies, and multistate cooperative purchasing alliances. Small Local Business Enterprise (SLBE) set-asides appear in Tampa's solicitation at a 5 percent bid discount, not to exceed $10,000. All solicitations require FDA compliance, cGMP or equivalent certification, Safety Data Sheets per OSHA standards, and minimum shelf-life and expiration-date warranties typically of six months to one year.